Published: 31 January 2013
An automated artificial pancreas under development simulates the normal pancreas by continuously adapting insulin delivery, Canadian researchers say. Dr. Remi Rabasa-Lhoret, endocrinologist at the Institut de recherches cliniques de Montreal at the University of Montreal, said a trial compared the dual-hormone artificial pancreas with conventional diabetes treatment using an insulin pump… "We found that the artificial pancreas improved glucose control by 15 percent and significantly reduced the risk of hypoglycemia as compared with conventional insulin pump therapy," first author Ahmad Haidar, a doctoral student at Rabasa-Lhoret's research unit and Ï㽶ÊÓƵ, said in a statement.